O	0	7	Changes
O	8	10	in
O	11	15	body
O	16	22	weight
O	23	26	and
O	27	36	metabolic
O	37	44	indexes
O	45	47	in
B-condition	48	58	overweight
O	59	65	breast
O	66	72	cancer
O	73	82	survivors
O	83	91	enrolled
O	92	94	in
O	95	96	a
O	97	107	randomized
O	108	113	trial
O	114	116	of
B-intervention	117	120	low
I-intervention	120	121	-
I-intervention	121	124	fat
O	125	127	vs
O	127	128	.
B-control	129	136	reduced
I-control	137	149	carbohydrate
I-control	150	155	diets
O	155	156	.

O	157	167	Overweight
O	168	174	status
O	175	177	is
O	178	184	common
O	185	190	among
O	191	196	women
O	197	203	breast
O	204	210	cancer
O	211	220	survivors
O	221	224	and
O	225	231	places
O	232	236	them
O	237	239	at
O	240	247	greater
O	248	252	risk
O	253	256	for
O	257	266	metabolic
O	267	276	disorders
O	276	277	,
O	278	292	cardiovascular
O	293	302	morbidity
O	302	303	,
O	304	307	and
O	308	314	breast
O	315	321	cancer
O	322	332	recurrence
O	333	337	than
O	338	351	nonoverweight
O	352	361	survivors
O	361	362	.

O	363	370	Efforts
O	371	373	to
O	374	381	promote
O	382	388	weight
O	389	396	control
O	397	399	in
O	400	404	this
O	405	415	population
O	416	419	are
O	420	426	needed
O	426	427	.

O	428	431	The
O	432	441	objective
O	442	444	of
O	445	449	this
O	450	458	research
O	459	462	was
O	463	465	to
O	466	474	evaluate
O	475	478	the
O	479	485	effect
O	486	488	of
O	489	492	low
O	492	493	-
O	493	496	fat
O	497	499	or
O	500	503	low
O	503	504	-
O	504	516	carbohydrate
O	517	521	diet
O	522	532	counseling
O	533	535	on
O	536	542	weight
O	543	547	loss
O	547	548	,
O	549	553	body
O	554	565	composition
O	565	566	,
O	567	570	and
O	571	578	changes
O	579	581	in
O	582	591	metabolic
O	592	599	indexes
O	600	602	in
B-eligibility	603	613	overweight
I-eligibility	614	628	postmenopausal
I-eligibility	629	635	breast
I-eligibility	636	642	cancer
I-eligibility	643	652	survivors
O	652	653	.

O	654	663	Survivors
O	664	665	(
O	665	666	n
O	667	668	=
B-total-participants	669	671	40
O	671	672	)
O	673	677	were
O	678	688	randomized
O	689	691	to
O	692	699	receive
O	700	709	dietitian
O	710	720	counseling
O	721	724	for
O	725	726	a
O	727	730	low
O	730	731	-
O	731	734	fat
O	735	737	or
O	738	739	a
O	740	747	reduced
O	748	760	carbohydrate
O	761	765	diet
O	766	769	for
O	770	771	6
O	772	774	mo
O	774	775	.

O	776	782	Weight
O	783	786	and
O	787	796	metabolic
O	797	805	measures
O	805	806	,
O	807	816	including
O	817	824	glucose
O	824	825	,
O	826	833	insulin
O	833	834	,
O	835	840	HbA1c
O	840	841	,
O	842	846	HOMA
O	846	847	,
O	848	854	lipids
O	854	855	,
O	856	861	hsCRP
O	861	862	,
O	863	865	as
O	866	870	well
O	871	873	as
O	874	879	blood
O	880	888	pressure
O	889	893	were
O	894	902	measured
O	903	905	at
O	906	914	baseline
O	914	915	,
O	916	917	6
O	917	918	,
O	919	921	12
O	922	925	and
O	926	928	24
O	929	931	wk
O	931	932	.

B-outcome	933	940	Dietary
I-outcome	941	947	intake
I-outcome	948	950	of
I-outcome	951	954	fat
I-outcome	955	958	and
I-outcome	959	971	carbohydrate
O	972	975	was
O	976	983	reduced
O	984	986	by
B-iv-cont-mean	987	989	24
O	990	993	and
B-cv-cont-mean	994	996	76
I-cv-cont-mean	997	998	g
I-cv-cont-mean	998	999	/
I-cv-cont-mean	999	1002	day
O	1002	1003	,
O	1004	1016	respectively
O	1016	1017	.

B-outcome	1018	1024	Weight
I-outcome	1025	1029	loss
O	1030	1038	averaged
O	1039	1040	6
O	1040	1041	.
O	1041	1042	1
O	1043	1044	(
O	1044	1045	±
O	1046	1047	4
O	1047	1048	.
O	1048	1049	8
O	1050	1052	kg
O	1052	1053	)
O	1054	1056	at
O	1057	1059	24
O	1060	1062	wk
O	1063	1066	and
O	1067	1070	was
O	1071	1074	not
O	1075	1088	significantly
O	1089	1098	different
O	1099	1101	by
O	1102	1106	diet
O	1107	1112	group
O	1112	1113	;
B-outcome	1114	1118	loss
I-outcome	1119	1121	of
I-outcome	1122	1126	lean
I-outcome	1127	1131	mass
O	1132	1135	was
O	1136	1140	also
O	1141	1153	demonstrated
O	1153	1154	.

O	1155	1158	All
O	1159	1167	subjects
O	1168	1180	demonstrated
O	1181	1193	improvements
O	1194	1196	in
B-outcome	1197	1202	total
I-outcome	1202	1203	/
I-outcome	1203	1206	HDL
I-outcome	1207	1218	cholesterol
I-outcome	1219	1224	ratio
O	1224	1225	,
O	1226	1229	and
O	1230	1241	significant
B-outcome	1242	1252	reductions
I-outcome	1253	1255	in
I-outcome	1256	1261	HbA1c
I-outcome	1261	1262	,
I-outcome	1263	1270	insulin
I-outcome	1270	1271	,
I-outcome	1272	1275	and
I-outcome	1276	1280	HOMA
O	1280	1281	.

B-outcome	1282	1295	Triglycerides
I-outcome	1296	1302	levels
O	1303	1307	were
O	1308	1321	significantly
O	1322	1329	reduced
O	1330	1334	only
O	1335	1337	in
O	1338	1341	the
O	1342	1345	low
O	1345	1346	-
O	1346	1358	carbohydrate
O	1359	1363	diet
O	1364	1369	group
O	1370	1371	(
B-cv-cont-mean	1371	1372	-
I-cv-cont-mean	1372	1374	31
I-cv-cont-mean	1374	1375	.
I-cv-cont-mean	1375	1376	1
O	1377	1378	±
B-cv-cont-sd	1379	1381	36
I-cv-cont-sd	1381	1382	.
I-cv-cont-sd	1382	1383	6
O	1383	1384	;
O	1385	1386	P
O	1387	1388	=
O	1389	1390	0
O	1390	1391	.
O	1391	1393	01
O	1393	1394	)
O	1394	1395	.

O	1396	1407	Significant
O	1408	1420	improvements
O	1421	1423	in
O	1424	1430	weight
O	1431	1434	and
O	1435	1444	metabolic
O	1445	1452	indexes
O	1453	1456	can
O	1457	1459	be
O	1460	1472	demonstrated
O	1473	1478	among
O	1479	1489	overweight
O	1490	1496	breast
O	1497	1503	cancer
O	1504	1513	survivors
O	1514	1522	adherent
O	1523	1525	to
O	1526	1532	either
O	1533	1534	a
O	1535	1547	carbohydrate
O	1547	1548	-
O	1549	1551	or
O	1552	1555	fat
O	1555	1556	-
O	1556	1566	restricted
O	1567	1571	diet
O	1571	1572	.
